Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about GAIN: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
No AI portrait yet
| Gene Symbol | GAIN |
| Full Name | GAIN - GABA-A Receptor Associated Protein Like 2 |
| Aliases | Page for GAIN Gene, GABARAPL2 |
| Chromosome | 16p13.3 |
| Protein Type | Gene |
| Function | encodes a protein belonging to the GABA-A receptor-associated protein (GABARAP) family. |
| Primary Expression | various tissues with high expression in: - Brain (particularly in neurons) - Heart - Skeletal muscle |
| Pathways | Akt, Apoptosis, Autophagy, Cell Cycle, Cholesterol Metabolism |
| NCBI Gene ID | 124454 |
| GeneCards | GAIN |
| Human Protein Atlas | GAIN |
| Associated Diseases | aging, Als, Alzheimer, Alzheimer'S Disease, Amyotrophic Lateral Sclerosis |
| Interactions | ACAT1, ACC, ACHE, Actin, AGING, AIF |
| KG Connections | 1870 knowledge graph edges |
| Databases | GeneCardsUniProtHPASTRING |
Knowledge base pages for this entity
graph TD
GAIN["GAIN"] -->|"activates"| Cancer["Cancer"]
GAIN["GAIN"] -->|"activates"| Carcinoma["Carcinoma"]
GAIN["GAIN"] -->|"activates"| Ms["Ms"]
GAIN["GAIN"] -->|"activates"| Als["Als"]
GAIN["GAIN"] -->|"biomarker for"| Neuroinflammation["Neuroinflammation"]
GAIN["GAIN"] -->|"biomarker for"| Inflammation["Inflammation"]
TIGAR["TIGAR"] -->|"activates"| GAIN["GAIN"]
IDH2["IDH2"] -->|"activates"| GAIN["GAIN"]
TMEM119["TMEM119"] -->|"biomarker for"| GAIN["GAIN"]
P2RY12["P2RY12"] -->|"biomarker for"| GAIN["GAIN"]
style GAIN fill:#4a1a6b,stroke:#4fc3f7,stroke-width:2px,color:#e0e0e0| Target | Relation | Type | Str |
|---|---|---|---|
| Inflammation | activates | disease | 1.00 |
| Als | causes | disease | 1.00 |
| Neurodegeneration | activates | disease | 1.00 |
| Tumor | activates | disease | 1.00 |
| Als | activates | disease | 1.00 |
| CANCER | associated_with | gene | 1.00 |
| Cancer | activates | disease | 1.00 |
| CANCER | therapeutic_target | gene | 1.00 |
| Cancer | therapeutic_target | disease | 1.00 |
| Als | therapeutic_target | disease | 1.00 |
| Tumor | inhibits | disease | 1.00 |
| Cancer | associated_with | disease | 1.00 |
| Tumor | associated_with | disease | 1.00 |
| Als | associated_with | disease | 1.00 |
| GENES | activates | gene | 1.00 |
| Apoptosis | activates | pathway | 1.00 |
| Apoptosis | implicated_in | pathway | 1.00 |
| INFLAMMATION | activates | gene | 1.00 |
| PI3K | therapeutic_target | gene | 1.00 |
| Als | expressed_in | disease | 0.95 |
| Inflammation | regulates | disease | 0.95 |
| Inflammation | therapeutic_target | disease | 0.95 |
| Aging | therapeutic_target | disease | 0.95 |
| Cancer | causes | disease | 0.95 |
| Tumor | therapeutic_target | disease | 0.95 |
| DNA | therapeutic_target | gene | 0.90 |
| Autophagy | activates | pathway | 0.90 |
| CANCER | activates | gene | 0.90 |
| GENES | therapeutic_target | gene | 0.90 |
| DNA | activates | gene | 0.90 |
| AKT | therapeutic_target | gene | 0.90 |
| Autoimmune | therapeutic_target | disease | 0.85 |
| Cancer | inhibits | disease | 0.85 |
| Breast Cancer | therapeutic_target | disease | 0.85 |
| Obesity | activates | disease | 0.85 |
| Diabetes | therapeutic_target | disease | 0.85 |
| Amyotrophic Lateral Sclerosis | therapeutic_target | disease | 0.85 |
| ASTROCYTES | activates | gene | 0.80 |
| P53 | associated_with | gene | 0.80 |
| Immune Response | activates | pathway | 0.80 |
| DNA | associated_with | gene | 0.80 |
| GENES | associated_with | gene | 0.80 |
| Autophagy | implicated_in | pathway | 0.80 |
| Glycolysis | activates | pathway | 0.80 |
| TP53 | implicated_in | gene | 0.80 |
| Nf-Κb | activates | pathway | 0.80 |
| ALS | causes | gene | 0.80 |
| Oxidative Stress | activates | pathway | 0.80 |
| AMYLOID | activates | gene | 0.80 |
| Cell Cycle | implicated_in | pathway | 0.80 |
| Source | Relation | Type | Str |
|---|---|---|---|
| APOPTOSIS | activates | gene | 1.00 |
| CANCER | therapeutic_target | gene | 1.00 |
| APOPTOSIS | implicated_in | gene | 1.00 |
| PTEN | therapeutic_target | gene | 0.90 |
| GENES | therapeutic_target | gene | 0.90 |
| NEURODEGENERATION | activates | gene | 0.80 |
| HUNTINGTON | associated_with | gene | 0.70 |
| TNF | regulates | gene | 0.70 |
| PIEZO1 | associated_with | gene | 0.70 |
| PINK1 | therapeutic_target | gene | 0.70 |
| AUTOPHAGY | activates | gene | 0.70 |
| TREM2 | activates | gene | 0.70 |
| DNA | associated_with | gene | 0.70 |
| C9ORF72 | activates | gene | 0.70 |
| SOD1 | therapeutic_target | gene | 0.70 |
| DNA | therapeutic_target | gene | 0.70 |
| CANCER | biomarker_for | gene | 0.70 |
| NEURODEGENERATION | regulates | gene | 0.70 |
| C9ORF72 | protects_against | gene | 0.60 |
| FIG4 | expressed_in | gene | 0.60 |
| JUN | activates | gene | 0.60 |
| ALS2 | expressed_in | gene | 0.60 |
| SUCLG1 | regulates | gene | 0.60 |
| STING1 | associated_with | gene | 0.60 |
| HSP70 | activates | gene | 0.60 |
| CALB1 | associated_with | gene | 0.60 |
| KCNN3 | associated_with | gene | 0.60 |
| GRIN2B | associated_with | gene | 0.60 |
| CAV1 | associated_with | gene | 0.60 |
| TKT | activates | gene | 0.60 |
| OPTN | expressed_in | gene | 0.60 |
| VCP | activates | gene | 0.60 |
| TMEM119 | biomarker_for | gene | 0.60 |
| STING | associated_with | gene | 0.60 |
| CD8 | expressed_in | gene | 0.60 |
| TIA1 | activates | gene | 0.60 |
| TP53 | activates | gene | 0.60 |
| SOD1 | inhibits | gene | 0.60 |
| LDLR | inhibits | gene | 0.60 |
| CHUK | inhibits | gene | 0.60 |
| PIK3CA | associated_with | gene | 0.60 |
| SOX2 | biomarker_for | gene | 0.60 |
| ATM | biomarker_for | gene | 0.60 |
| P62 | inhibits | gene | 0.60 |
| RANKL | activates | gene | 0.60 |
| BRAF | therapeutic_target | gene | 0.60 |
| TET2 | therapeutic_target | gene | 0.60 |
| STAT3 | activates | gene | 0.60 |
| OVERVIEW | therapeutic_target | gene | 0.60 |
| GABRA1 | associated_with | gene | 0.60 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| G2019S primarily raises baseline LRRK2 kinase activity rathe | 0.790 | neurodegeneration | Do pathogenic LRRK2 mutations amplify vo |
| SIRT1/PGC-1α Axis Activation to Preserve Mitochondrial Resil | 0.778 | neurodegeneration | Gut Microbiome Analysis in Parkinson's D |
| Granzyme B Inhibition with Serpina3n to Preserve Axonal Inte | 0.698 | neuroimmunology | Do CXCL10-recruited CD8+ T cells provide |
| DAPK1 Inhibition as Dual-Mechanism Neuroprotection Against T | 0.604 | neurodegeneration | Should microtubule-stabilizing drugs be |
| ω-3 Docosahexaenoic Acid (DHA) Metabolism via 15-Lipoxygenas | 0.380 | lipidomics | Lipid metabolism dysregulation in Alzhei |
Scientific analyses that reference this entity
No analyses mention this entity
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| PGC-1α knockout analysis of PV+ interneuron maturation | validation | neurodevelopmental disorders | 0.850 | 0.00 | knockout mice | proposed | N/A |
| PV+ interneuron subtype diversification analysis | exploratory | neurodevelopmental disorders | 0.750 | 0.00 | mouse cortical PV+ interneuron | proposed | N/A |
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| Enhancing TREM2 expression activates microglia and modestly mitigates tau pathol [PMID:40122810] | ["Chen Kai", "Li Fuyao", "Zhang Shuwen", | Journal of neuroinflammation | 2025 | 0 |
| Enhancing TREM2 expression activates microglia and modestly mitigates tau pathol [PMID:40122810] | ["Chen Kai", "Li Fuyao", "Zhang Shuwen", | Journal of neuroinflammation | 2025 | 0 |
| LRRK2 kinase-mediated accumulation of lysosome-associated phospho-Rabs in tauopa [PMID:41128923] | Buck SA, Malankhanova T, Strader S, Ma E | Acta neuropathologica | 2025 | 0 |
| RAB12-LRRK2 complex suppresses primary ciliogenesis and regulates centrosome hom [PMID:39343966] | Li X, Zhu H, Huang BT, Li X, Kim H, Tan | Nature communications | 2024 | 0 |
| Exploring the focal role of LRRK2 kinase in Parkinson's disease. [PMID:35147886] | ["Kumar Sachin", "Behl Tapan", "Sehgal A | Environmental science and poll | 2022 | 0 |
| Elevated Urinary Rab10 Phosphorylation in Idiopathic Parkinson Disease. [PMID:35521944] | Wang S, Unnithan S, Bryant N | Mov Disord | 2022 | 0 |
| Neurodegeneration and Inflammation-An Interesting Interplay in Parkinson's Disea [PMID:33182554] | Marogianni C, Sokratous M, Dardiotis E, | International journal of molec | 2020 | 0 |
| Neurodegeneration and Inflammation-An Interesting Interplay in Parkinson's Disea [PMID:33182554] | Marogianni C, Sokratous M, Dardiotis E, | International journal of molec | 2020 | 0 |
| Rab GTPases as Physiological Substrates of LRRK2 Kinase. [PMID:31138985] | Seol W, Nam D, Son I | Exp Neurobiol | 2019 | 0 |
| Multiple Sclerosis Pathology. [PMID:29358320] | Lassmann H | Cold Spring Harbor perspective | 2018 | 0 |
Multi-agent debates referencing this entity
No debates reference this entity
Hypotheses and analyses mentioning GAIN in their description or question text
No additional research found